216 related articles for article (PubMed ID: 21295418)
1. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study.
Manzoni P; Lista G; Gallo E; Marangione P; Priolo C; Fontana P; Guardione R; Farina D
Early Hum Dev; 2011 Mar; 87 Suppl 1():S35-8. PubMed ID: 21295418
[TBL] [Abstract][Full Text] [Related]
2. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants.
Uberos J; Aguilera-Rodríguez E; Jerez-Calero A; Molina-Oya M; Molina-Carballo A; Narbona-López E
Br J Nutr; 2017 Apr; 117(7):994-1000. PubMed ID: 28443531
[TBL] [Abstract][Full Text] [Related]
3. Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.
Kane AF; Bhatia AD; Denning PW; Shane AL; Patel RM
J Pediatr; 2018 Apr; 195():73-79.e2. PubMed ID: 29402455
[TBL] [Abstract][Full Text] [Related]
4. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG.
Luoto R; Matomäki J; Isolauri E; Lehtonen L
Acta Paediatr; 2010 Aug; 99(8):1135-8. PubMed ID: 20219023
[TBL] [Abstract][Full Text] [Related]
5. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.
Pammi M; Suresh G
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007137. PubMed ID: 28658720
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial.
Manzoni P; Meyer M; Stolfi I; Rinaldi M; Cattani S; Pugni L; Romeo MG; Messner H; Decembrino L; Laforgia N; Vagnarelli F; Memo L; Bordignon L; Maule M; Gallo E; Mostert M; Quercia M; Bollani L; Pedicino R; Renzullo L; Betta P; Ferrari F; Alexander T; Magaldi R; Farina D; Mosca F; Stronati M
Early Hum Dev; 2014 Mar; 90 Suppl 1():S60-5. PubMed ID: 24709463
[TBL] [Abstract][Full Text] [Related]
7. Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin.
Meyer MP; Alexander T
J Neonatal Perinatal Med; 2017; 10(3):249-255. PubMed ID: 28854514
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
Manzoni P; Rinaldi M; Cattani S; Pugni L; Romeo MG; Messner H; Stolfi I; Decembrino L; Laforgia N; Vagnarelli F; Memo L; Bordignon L; Saia OS; Maule M; Gallo E; Mostert M; Magnani C; Quercia M; Bollani L; Pedicino R; Renzullo L; Betta P; Mosca F; Ferrari F; Magaldi R; Stronati M; Farina D;
JAMA; 2009 Oct; 302(13):1421-8. PubMed ID: 19809023
[TBL] [Abstract][Full Text] [Related]
9. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.
Grev J; Berg M; Soll R
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012519. PubMed ID: 30548483
[TBL] [Abstract][Full Text] [Related]
10. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
Pammi M; Abrams SA
Cochrane Database Syst Rev; 2015 Feb; (2):CD007137. PubMed ID: 25699678
[TBL] [Abstract][Full Text] [Related]
11. Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study.
Li D; Rosito G; Slagle T
J Clin Pharm Ther; 2013 Dec; 38(6):445-9. PubMed ID: 23865733
[TBL] [Abstract][Full Text] [Related]
12. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.
Sari FN; Dizdar EA; Oguz S; Erdeve O; Uras N; Dilmen U
Eur J Clin Nutr; 2011 Apr; 65(4):434-9. PubMed ID: 21245887
[TBL] [Abstract][Full Text] [Related]
13. Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect.
Manzoni P; García Sánchez R; Meyer M; Stolfi I; Pugni L; Messner H; Cattani S; Betta PM; Memo L; Decembrino L; Bollani L; Rinaldi M; Fioretti M; Quercia M; Maule M; Tavella E; Mussa A; Tzialla C; Laforgia N; Mosca F; Magaldi R; Mostert M; Farina D;
J Pediatr; 2018 Feb; 193():62-67.e1. PubMed ID: 29198543
[TBL] [Abstract][Full Text] [Related]
14. Cohort study of probiotics in a North American neonatal intensive care unit.
Janvier A; Malo J; Barrington KJ
J Pediatr; 2014 May; 164(5):980-5. PubMed ID: 24411521
[TBL] [Abstract][Full Text] [Related]
15. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
Venkatesh MP; Abrams SA
Cochrane Database Syst Rev; 2010 May; (5):CD007137. PubMed ID: 20464748
[TBL] [Abstract][Full Text] [Related]
16. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
Rougé C; Piloquet H; Butel MJ; Berger B; Rochat F; Ferraris L; Des Robert C; Legrand A; de la Cochetière MF; N'Guyen JM; Vodovar M; Voyer M; Darmaun D; Rozé JC
Am J Clin Nutr; 2009 Jun; 89(6):1828-35. PubMed ID: 19369375
[TBL] [Abstract][Full Text] [Related]
17. Association of Hospital Adoption of Probiotics With Outcomes Among Neonates With Very Low Birth Weight.
Agha L; Staiger D; Brown C; Soll RF; Horbar JD; Edwards EM
JAMA Health Forum; 2023 May; 4(5):e230960. PubMed ID: 37171798
[TBL] [Abstract][Full Text] [Related]
18. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants.
Pammi M; Abrams SA
Cochrane Database Syst Rev; 2011 Oct; (10):CD007137. PubMed ID: 21975765
[TBL] [Abstract][Full Text] [Related]
19. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.
Manzoni P; Mostert M; Leonessa ML; Priolo C; Farina D; Monetti C; Latino MA; Gomirato G
Clin Infect Dis; 2006 Jun; 42(12):1735-42. PubMed ID: 16705580
[TBL] [Abstract][Full Text] [Related]
20. Effect of Donor Milk on Severe Infections and Mortality in Very Low-Birth-Weight Infants: The Early Nutrition Study Randomized Clinical Trial.
Corpeleijn WE; de Waard M; Christmann V; van Goudoever JB; Jansen-van der Weide MC; Kooi EM; Koper JF; Kouwenhoven SM; Lafeber HN; Mank E; van Toledo L; Vermeulen MJ; van Vliet I; van Zoeren-Grobben D
JAMA Pediatr; 2016 Jul; 170(7):654-61. PubMed ID: 27135598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
